Risk thresholds for patients to switch between daily tablets and biweekly infusions in second-line treatment for advanced hepatocellular carcinoma: a patient preference study

Overview of attention for article published in BMC Cancer, January 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

So far, Dimensions has found 2 publications that cite this research output.

Article in Value in Health (February 2024)

Article in BMC Gastroenterology (February 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.